• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YAP/TEAD4/SP1诱导的VISTA表达作为结直肠癌免疫抑制的肿瘤细胞内在机制。

YAP/TEAD4/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer.

作者信息

Zhu Zhehui, Ding Rui, Yu Wei, Liu Yun, Zhou Zhaocai, Liu Chen-Ying

机构信息

Department of Colorectal and Anal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.

State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, 200438, China.

出版信息

Cell Death Differ. 2025 May;32(5):911-925. doi: 10.1038/s41418-025-01446-2. Epub 2025 Jan 28.

DOI:10.1038/s41418-025-01446-2
PMID:39875519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12089306/
Abstract

Hyperactivation of the YAP/TEAD transcriptional complex in cancers facilitates the development of an immunosuppressive tumor microenvironment. Herein, we observed that the transcription factor SP1 physically interacts with and stabilizes the YAP/TEAD complex at regulatory genomic loci in colorectal cancer (CRC). In response to serum stimulation, PKCζ (protein kinase C ζ) was found to phosphorylate SP1 and enhance its interaction with TEAD4. As a result, SP1 enhanced the transcriptional activity of YAP/TEAD and coregulated the expression of a group of YAP/TEAD target genes. The immune checkpoint V-domain Ig suppressor of T-cell activation (VISTA) was identified as a direct target of the SP1-YAP/TEAD4 complex and found to be widely expressed in CRC cells. Importantly, YAP-induced VISTA upregulation in human CRC cells was found to strongly suppress the antitumor function of CD8 T cells. Consistently, elevated VISTA expression was found to be correlated with hyperactivation of the SP1-YAP/TEAD axis and associated with poor prognosis of CRC patients. In addition, we found by serendipity that enzymatic deglycosylation significantly improved the anti-VISTA antibody signal intensity, resulting in more accurate detection of VISTA in clinical tumor samples. Overall, our study identified SP1 as a positive modulator of YAP/TEAD for the transcriptional regulation of VISTA and developed a protein deglycosylation strategy to better detect VISTA expression in clinical samples. These findings revealed a new tumor cell-intrinsic mechanism of YAP/TAZ-mediated cancer immune evasion.

摘要

YAP/TEAD转录复合物在癌症中的过度激活促进了免疫抑制性肿瘤微环境的形成。在此,我们观察到转录因子SP1在结直肠癌(CRC)的调控基因组位点与YAP/TEAD复合物发生物理相互作用并使其稳定。在血清刺激下,发现蛋白激酶Cζ(PKCζ)使SP1磷酸化并增强其与TEAD4的相互作用。结果,SP1增强了YAP/TEAD的转录活性,并共同调节一组YAP/TEAD靶基因的表达。免疫检查点T细胞激活V结构域Ig抑制因子(VISTA)被鉴定为SP1-YAP/TEAD4复合物的直接靶标,并发现其在CRC细胞中广泛表达。重要的是,发现YAP诱导的人CRC细胞中VISTA上调强烈抑制CD8 T细胞的抗肿瘤功能。一致地,发现VISTA表达升高与SP1-YAP/TEAD轴的过度激活相关,并与CRC患者的不良预后相关。此外,我们偶然发现酶促去糖基化显著提高了抗VISTA抗体的信号强度,从而在临床肿瘤样本中更准确地检测VISTA。总体而言,我们的研究确定SP1是YAP/TEAD对VISTA进行转录调控的正向调节因子,并开发了一种蛋白质去糖基化策略以更好地检测临床样本中的VISTA表达。这些发现揭示了YAP/TAZ介导的癌症免疫逃逸的一种新的肿瘤细胞内在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/b37f93b2e6ae/41418_2025_1446_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/aa70d1cbeb60/41418_2025_1446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/036cd5f44a06/41418_2025_1446_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/e71d9865ae38/41418_2025_1446_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/a454138853bb/41418_2025_1446_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/5496fa398a4d/41418_2025_1446_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/140f2d271516/41418_2025_1446_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/b37f93b2e6ae/41418_2025_1446_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/aa70d1cbeb60/41418_2025_1446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/036cd5f44a06/41418_2025_1446_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/e71d9865ae38/41418_2025_1446_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/a454138853bb/41418_2025_1446_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/5496fa398a4d/41418_2025_1446_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/140f2d271516/41418_2025_1446_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b9/12089306/b37f93b2e6ae/41418_2025_1446_Fig7_HTML.jpg

相似文献

1
YAP/TEAD4/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer.YAP/TEAD4/SP1诱导的VISTA表达作为结直肠癌免疫抑制的肿瘤细胞内在机制。
Cell Death Differ. 2025 May;32(5):911-925. doi: 10.1038/s41418-025-01446-2. Epub 2025 Jan 28.
2
CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis.CK2 诱导 HHEX 与 YAP-TEAD4 复合物合作促进结直肠肿瘤发生。
Nat Commun. 2022 Aug 25;13(1):4995. doi: 10.1038/s41467-022-32674-6.
3
Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.结直肠癌中TEAD4表达增加及核定位以不依赖YAP的方式促进上皮-间质转化和转移。
Oncogene. 2016 May;35(21):2789-800. doi: 10.1038/onc.2015.342. Epub 2015 Sep 21.
4
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.TEA 结构域转录因子 4 是 Yes 相关蛋白致癌活性在人和鼠肝母细胞瘤中的主要介质。
Am J Pathol. 2019 May;189(5):1077-1090. doi: 10.1016/j.ajpath.2019.01.016. Epub 2019 Feb 19.
5
Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma.靶向YAP/TAZ-TEAD信号传导作为头颈鳞状细胞癌的一种治疗方法。
Cancer Lett. 2025 Mar 1;612:217467. doi: 10.1016/j.canlet.2025.217467. Epub 2025 Jan 16.
6
The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.受体酪氨酸激酶 EphA2 通过激活转录共激活因子 YAP 和 TAZ 促进肿瘤中的谷氨酰胺代谢。
Sci Signal. 2017 Dec 5;10(508):eaan4667. doi: 10.1126/scisignal.aan4667.
7
YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells.YAP/TAZ-TEAD 活性通过增强癌症干细胞的特性和瓦博格效应促进宫颈上皮内瘤变的恶性转化。
Apoptosis. 2024 Aug;29(7-8):1198-1210. doi: 10.1007/s10495-023-01935-0. Epub 2024 Mar 29.
8
Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.TEAD4的酰化对其与共激活因子YAP和TAZ相互作用的影响。
Protein Sci. 2017 Dec;26(12):2399-2409. doi: 10.1002/pro.3312. Epub 2017 Nov 11.
9
YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma.YAP/TEAD4 诱导的 KIF4A 促进食管鳞癌的进展和预后不良。
Mol Carcinog. 2021 Jul;60(7):440-454. doi: 10.1002/mc.23303. Epub 2021 May 18.
10
Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.p38丝裂原活化蛋白激酶(MAPK)诱导的细胞质转位对河马通路转录因子TEAD的调控
Nat Cell Biol. 2017 Jul 28;19(8):996-1002. doi: 10.1038/ncb3581.

引用本文的文献

1
Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential.肝细胞癌治疗中靶向免疫检查点:迈向具有治愈潜力的联合策略
Exp Hematol Oncol. 2025 May 2;14(1):65. doi: 10.1186/s40164-025-00636-5.

本文引用的文献

1
ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.ELK4 通过非经典的 SP1/3 依赖性方式激活新生血管因子 LRG1 促进结直肠癌进展。
Adv Sci (Weinh). 2023 Nov;10(32):e2303378. doi: 10.1002/advs.202303378. Epub 2023 Oct 2.
2
Control of stem cell renewal and fate by YAP and TAZ.YAP 和 TAZ 对干细胞更新和命运的控制。
Nat Rev Mol Cell Biol. 2023 Dec;24(12):895-911. doi: 10.1038/s41580-023-00644-5. Epub 2023 Aug 25.
3
ELK4 exerts opposite roles in cytokine/chemokine production and degranulation in activated mast cells.
ELK4 在激活的肥大细胞中细胞因子/趋化因子的产生和脱颗粒中发挥相反的作用。
Front Immunol. 2023 Jul 17;14:1171380. doi: 10.3389/fimmu.2023.1171380. eCollection 2023.
4
Insights into recent findings and clinical application of YAP and TAZ in cancer.YAP 和 TAZ 在癌症中的最新研究发现及其临床应用
Nat Rev Cancer. 2023 Aug;23(8):512-525. doi: 10.1038/s41568-023-00579-1. Epub 2023 Jun 12.
5
Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers.YAP/TAZ在胃肠道癌症中的作用及治疗潜力的最新见解。
Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188787. doi: 10.1016/j.bbcan.2022.188787. Epub 2022 Aug 28.
6
CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis.CK2 诱导 HHEX 与 YAP-TEAD4 复合物合作促进结直肠肿瘤发生。
Nat Commun. 2022 Aug 25;13(1):4995. doi: 10.1038/s41467-022-32674-6.
7
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.恶性胸膜间皮瘤的分子改变:通过靶向 YAP 实现有效治疗的希望。
Target Oncol. 2022 Jul;17(4):407-431. doi: 10.1007/s11523-022-00900-2. Epub 2022 Jul 30.
8
Programmed death ligand 1 signals in cancer cells.程序性死亡配体 1 在癌细胞中的信号转导。
Nat Rev Cancer. 2022 Mar;22(3):174-189. doi: 10.1038/s41568-021-00431-4. Epub 2022 Jan 14.
9
Spatially organized multicellular immune hubs in human colorectal cancer.人类结直肠癌中有空间组织的多细胞免疫中心。
Cell. 2021 Sep 2;184(18):4734-4752.e20. doi: 10.1016/j.cell.2021.08.003. Epub 2021 Aug 26.
10
Immune functions as a ligand or a receptor, cancer prognosis potential, clinical implication of VISTA in cancer immunotherapy.免疫功能作为配体或受体,VISTA 在癌症免疫治疗中的癌症预后潜能、临床意义。
Semin Cancer Biol. 2022 Nov;86(Pt 2):1066-1075. doi: 10.1016/j.semcancer.2021.08.008. Epub 2021 Aug 21.